Sidgiddi, S., Ranganathan, U. and Gautam, A. (2017) “DFD-03 (0.1% Tazarotene), Twice-daily, Short-Contact Lotion Formulation, Showed Similar Pharmacokinetic Exposure to the Marketed Cream Product with Once-Daily Overnight Application”, SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s46. doi: 10.25251/skin.1.supp.45.